+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

POWER Foundation Pilot Grant

Powell-Drescher Ovarian Cancer Research Foundation

The POWER Foundation is pleased to announce its Pilot Grant Award to encourage preliminary research projects in all areas of ovarian cancer research including, but not limited to, cancer biology, genetics, early detection and prevention, treatment, cancer care delivery, and public health sciences. New concepts, novel approaches, and/or projects that extend previous discoveries and have potential to develop into larger projects are encouraged.

To be considered responsive, the research team must include an ovarian cancer advocate. Project costs are not to exceed $75,000 direct costs budgeted over no more than two years duration. Institutional overhead and indirect cost rates are limited to 10%.

Investigators who have completed graduate training including individuals with MD, PhD, ScD, MSW, and MSN degrees are eligible to apply. Applicants should have a minimum of 50% protected research time. Principal Investigators must hold the equivalent of an Assistant Professor position or higher and be affiliated with an institution capable of administering the award funds.

Eligible Institutions include: Public or private institutions including universities, colleges, or hospitals as well as non-profit organizations.
Investigators associated with organizations that meet FDA criteria for a Significantly Regulated Organization (SRO) including foundations and non-profits associated with an SRO are not eligible to apply.

Although international participation is anticipated in future funding rounds, this POWER Foundation award is restricted to institutions within the US.

Application Timeline	Key Dates
Letter of Intent Due	May 29, 2026
Invitation to Submit Full Proposal	June 2026
Full Proposals Due	August 15th, 2026
Award Notification	November 2026
Projected Start Date	January 2027

AI Based Application Success Predictor

1. Direct Relevance to Ovarian Cancer (Strongest Predictor)

The Foundation exists specifically to advance ovarian cancer research. Successful applications typically focus on:

Ovarian cancer biology
Disease mechanisms
Early detection
Novel therapeutics
Prevention strategies
Survivorship and outcomes

Projects with only indirect relevance to ovarian cancer are generally less competitive.

2. Scientific Excellence and Innovation

Like most disease-focused cancer foundations, PDOCRF appears to prioritize:

Novel hypotheses
Innovative methodologies
Transformative scientific concepts
New approaches to longstanding challenges

Applications proposing incremental advances are generally less competitive than those offering meaningful innovation.

3. Translational and Clinical Impact

Competitive projects often demonstrate a clear path toward:

Improved patient outcomes
Earlier diagnosis
Better treatment selection
Reduced mortality
Improved quality of life

Foundations focused on ovarian cancer increasingly prioritize research that can move discoveries toward clinical application.

4. Focus on Unmet Needs

Historically successful ovarian cancer research proposals often address:

Platinum-resistant disease
Recurrent ovarian cancer
Early detection challenges
Treatment resistance
Rare ovarian cancer subtypes
Health disparities in care

Projects targeting major unmet clinical needs tend to attract strong reviewer interest.

5. Preliminary Data and Feasibility

Strong applications generally provide:

Pilot data
Proof-of-concept findings
Feasibility evidence
Access to relevant patient samples or models

Because foundation grants often serve as seed funding, reviewers typically seek evidence that proposed studies can produce meaningful results within the grant period.

6. Investigator Strength

Successful applicants commonly demonstrate:

Relevant publication record
Expertise in gynecologic oncology
Cancer biology experience
Prior productivity
Ability to complete the proposed work

For early-career investigators, evidence of strong mentorship may partially compensate for a shorter track record.

7. Biomarkers and Novel Therapeutics

Projects involving:

Precision medicine
Targeted therapies
Immunotherapy
Biomarker development
Genomic and molecular profiling
Early detection technologies

frequently align with modern ovarian cancer funding priorities.

8. Potential for Future Funding

Many ovarian cancer foundations view their grants as catalytic investments.

Competitive projects often:

Generate preliminary data
Establish new collaborations
Support future NIH applications
Create pathways to larger translational studies

9. Collaboration and Multidisciplinary Teams

Applications involving expertise from multiple disciplines often have advantages, including:

Gynecologic oncology
Molecular biology
Genomics
Bioinformatics
Immunology
Clinical trials

Collaborative approaches are increasingly common in funded ovarian cancer research.

10. Strong Research Environment

Reviewers generally favor institutions with:

Cancer center infrastructure
Access to ovarian cancer patient populations
Biobanks and tissue resources
Clinical research support
Translational research capabilities

A strong institutional environment increases confidence in successful project completion.

Frequently Funded Ovarian Cancer Themes

Across ovarian cancer foundations, including PDOCRF-type programs, frequently funded topics include:

Early detection and screening
Biomarker discovery
Precision oncology
Immunotherapy
Drug resistance mechanisms
Tumor microenvironment
BRCA-related ovarian cancer
PARP inhibitor resistance
Rare ovarian cancer subtypes
Survivorship and quality-of-life research

Funding Strategy

A highly competitive Powell-Drescher Ovarian Cancer Research Foundation application typically includes:

A clearly defined ovarian cancer research question.
Strong scientific innovation.
Clear translational relevance to patient care.
Preliminary data supporting feasibility.
An experienced investigative team.
Potential to generate future federal or major foundation funding.
A realistic pathway toward improving ovarian cancer diagnosis, treatment, or prevention.

Specialties

Biomedical Engineering

Genetics & Genomics

Cancer

Oncology

Eligibility Requirements

Eligible Countries:

United States

Sponsor Details

Sponsor Institute/Organizations: Powell-Drescher Ovarian Cancer Research Foundation

Sponsor Type: Corporate/Non-Profit

Address: 12345 Lake City Way NE, Suite 2201, Seattle, WA 98125

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity